Exosome Website - Headers (12)

* All times shown in EST

8:00 am Morning Speed Networking

Synopsis

Grab a coffee from the comfort of your own kitchen and jump into this 1:1 networking session to make new connections, exchange virtual business cards and maybe even see a friendly face or two!

8:50 am Chair’s Opening Remarks

EXOSOMES AS COVID-19 TREATMENT AGENTS

9:00 am Development of Therapeutic Exosomes

  • Linda Marbán Chief Executive Officer, Capricor Therapeutics, Inc.

9:30 am Radically Simplifying Production of hMSC-EVs for Therapeutic Product Development & Rapid Clinical Translation

9:45 am Group Discussion: What Methods are Successful in Scaling Exosomes? Is There Any Way We Can Improve These?

  • Lutz Ehrhardt Senior Marketing Manager, Beckman Coulter Life Sciences

10:15 am Comfort Break

UNCOVERING CELL BIOLOGY TO IMPROVE EXOSOMES AS DRUG DELIVERY VEHICLES

Moderator:
Xandra Breakefield
, Professor, Neurology & Geneticist, Neurology & Radiology,
Harvard Medical School & Massachusetts General Hospital

10:30 am Therapeutic Implications of Complex Signaling Networks on Exosomes that Orchestrates the Development of Neuronal Circuits

  • Pranav Sharma Staff Scientist & Founder & Chief Scientific Officer, Scripps Research & Xosomix

11:00 am Mesenchymal Stem Cell-Derived Extracellular Vesicles: Potential Modulators of the Immune System in Many Diseases

  • Bernd Giebel Group Leader, Institute for Transfusion Medicine, University Hospital Essen

11:30 am Fundamental Aspects & Therapeutic Applications of Live Imaging of Single EV In Vivo

  • Guillaume van Niel Research Director, Université de Paris, Institute of Psychiatry & Neuroscience of Paris (IPNP), INSERM

12:00 pm Virtual Speed Networking

Synopsis

Grab lunch from the comfort of your own kitchen and jump into this 1:1 networking session to make new connections, exchange virtual business cards and maybe even see a friendly face or two!

12:30 pm Purification of EVs From Infected Cells for Diagnostic & Therapeutic Purposes

1:00 pm Use of Stem Cell EVs as a Holistic Approach to CNS Repair

  • Heather Branscome Lead Biologist & PhD Candidate, American Type Culture Collection & George Mason University

1:30 pm MSC-NTF Exosomes as a Potential Treatment for Covid-19 ARDS & Related Disorders

2:00 pm Applying Placental MSC-Derived Exosomes to Treat Neurological Disorders & Congenital Diseases

  • Aijun Wang Associate Professor, Department of Surgery & Biomedical Engineering, University of California, Davis

2:30 pm Virtual Speed Networking

Synopsis

Grab a coffee from the comfort of your own kitchen and jump into this 1:1 networking session to make new connections, exchange virtual business cards and maybe even see a friendly face or two!

STREAMLINING COMMERCIALIZATION, PARTNERSHIPS & REGULATORY SUBMISSIONS

3:00 pm Commercializing Novel Therapeutics with Strategic Collaborations

  • Richard Brudnick Chief Business Officer & Head of Strategy, Codiak Biosciences

3:30 pm Pre-Clinical Development of Exosome-Based Therapeutics: Challenges, Barriers & Opportunities

  • Joana Correia Executive Director & Chief Scientific Officer, Exogenus Therapeutics SA

4:00 pm Early Stage Partnerships for Exosome Therapeutic Development: Considerations in Building Academic Alliances

  • Zera Ong Commercial and Legal Associate, Evox Therapeutics

4:30 pm Panel Discussion: Commercialization, Partnerships & Regulation

5:00 pm Chair’s Closing Remarks & End of 2nd Exosome Based Therapeutic Development Summit